Steve Spellman (@spellman_s) header
Steve Spellman (@spellman_s) profile picture

Steve Spellman

@spellman_s

Histocompatibility researcher. Proud Dad. Empty nester. Lifelong Midwesterner. All opinions tweeted are my own

Joined April 2012
  • Tweets673
  • Following510
  • Followers351
62Media
Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)Photo by Steve Spellman (@spellman_s)
This is why we are working tirelessly for #equaloutcomesforall @CIBMTR @BeTheMatch
J Mark Sloan (@Jmarksloan) profile pictureJ Mark Sloan@Jmarksloan1 Dec 2018
A less cynical reminder of why the work at #ASH18 is important #herosjourneyart
Image from J Mark Sloan (@Jmarksloan)
1
23
Our new @BMTCTN 1703 analysis busts a few myths: - QOL improved with ptCY - 🩸Cystitis not worse - 2yr GRFS superior 42% vs 29%, p=0.001 - ptCY relapse NOT higher @sghmd @GvHD_Meade TY to Mike Martens for elegant analysis #GvHD #alloHCT #BMT ascopubs.org/doi/10.1200/JCO…
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life...

Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life...

The BMT CTN 1703 phase III trial confirmed that graft-versus-host disease (GVHD) prophylaxis with post-transplantation cyclophosphamide (PTCy), tacrolimus (Tac), and mycophenolate mofetil (MMF)...

ascopubs.org
1
13
1
66
4,166
Steve Spellman retweeted
Arthur Caplan (@ArthurCaplan) profile picture
Arthur Caplan@ArthurCaplan6 Aug 2024
this guy vs. vance. r u kidding me. JD better scurry back to Yale
Democratic Wins Media (@DemocraticWins) profile pictureDemocratic Wins Media
@DemocraticWins6 Aug 2024
BREAKING: The Kamala Harris-Tim Walz campaign just released their first ad highlighting who Tim Walz is and what he is about. Retweet to make sure every American knows Tim Walz and what he stands for.
1
2
20
1,478
Steve Spellman retweeted
CIBMTR (@CIBMTR) profile picture
CIBMTR@CIBMTR5 Aug 2024
The largest ever long-term study of people who donated peripheral blood stem cells (#PBSC) show that medicines for these donations are safe. Learn more about this recent CIBMTR study: cibmtr.org/Files/Patient-Sum…
Image from CIBMTR (@CIBMTR)
8
3
18
4,544
Steve Spellman retweeted
Moshe Israeli (@israelimoshe) profile picture
Moshe Israeli@israelimoshe24 Apr 2023
Brilliant presentation by Dr. B. Shaw from @CIBMTR about the era of PTCy #transplantation from unrelated donors. Our long time conceptions about #HLA match significance may need to be updated. Joint @TheEBMT @WMDA_office session at #EBMT2023. #lifeinHLA #immunogenetics – at Paris, France
Image from Moshe Israeli (@israelimoshe)
Image from Moshe Israeli (@israelimoshe)
4
14
864
💯
This Post is from an account that no longer exists. Learn more
2
156
The commentary on the study led by @LorenGragert, @spellman_s, Bronwen Shaw, and @martinmaiers can be found here: doi.org/10.1016/j.jtct.2023.…. @ASTCT @BeTheMatch @Tulane @MedicalCollege
1
1
244
Great opportunity for young investigators to join a working committee @CIBMTR @spellman_s @kidsBMTdoc Application closing soon! cibmtr.org/CIBMTR/Utility-Na…
5
8
1,200
Steve Spellman retweeted
NMDP (@nmdp_org) profile picture
NMDP@nmdp_org7 Mar 2023
Exciting news! The NMDP/#BeTheMatch, @CIBMTR & @nih_nhlbi have published findings from the Pre-MEASURE study in @JAMA_current. 🔬 This research gives insights on #MRD as a tool to inform #HCT decisions for patients with #AML to improve outcomes. Read more: https://nitter.gq/t.co/mqRizAdZV7
Image from NMDP (@nmdp_org)
8
1
19
3,411
Steve Spellman retweeted
NIH (@NIH) profile picture
NIH
@NIH7 Mar 2023
News: Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant dlvr.it/SkWFwD
2
13
1
32
15,093
Steve Spellman retweeted
NMDP (@nmdp_org) profile picture
NMDP@nmdp_org6 Mar 2023
Listen up! 🎧 The latest episode of the Explore Cell Therapy podcast is now available. Hear more from @spellman_s and @JeffAuletta about efforts to close equity gaps to ensure a donor is available for all patients who need allogeneic #HCT. Catch up now 👉 https://nitter.gq/t.co/2M79gs0JoT
3
11
2,239
MCC Director Douglas Yee says that biomarker analysis has changed the way we treat breast cancer. It's crucial that more Minnesotans can access this type of testing! Join us in telling the #mnleg to pass SF1948 so more Minnesotans can access #precisionmedicine.
Image from Masonic Cancer Center, University of Minnesota (@UMNCancer)
5
15
847
Steve Spellman retweeted
NMDP (@nmdp_org) profile picture
NMDP@nmdp_org2 Mar 2023
Ready to discover the latest research on #MRD and precision medicine for #AML patients post-allogeneic #HCT? Join Chief Scientific Director @JeffAuletta for a roundtable discussion with our expert panel to learn more & earn CME credits. 📅 March 9 👉 https://nitter.gq/t.co/Uf7QyVwntk
Image from NMDP (@nmdp_org)
9
1
17
3,515
Steve Spellman retweeted
Jeff Auletta (@JeffAuletta) profile picture
Jeff Auletta@JeffAuletta3 Mar 2023
Great panel of speakers discussing Pre-MEASURE findings, presenting case reports, and reviewing MEASURE study PI @DrChrisHourigan
NMDP (@nmdp_org) profile pictureNMDP@nmdp_org2 Mar 2023
Ready to discover the latest research on #MRD and precision medicine for #AML patients post-allogeneic #HCT? Join Chief Scientific Director @JeffAuletta for a roundtable discussion with our expert panel to learn more & earn CME credits. 📅 March 9 👉 https://nitter.gq/t.co/Uf7QyVwntk
Image from NMDP (@nmdp_org)
3
14
1,590
Be the Match Day of Action: Support blood cancer and blood disease patients today! @BTMPublicPolicy votervoice.net/Shares/BwNB2A…
1
8
207
💯
Vincent Rajkumar (@VincentRK) profile pictureVincent Rajkumar
@VincentRK1 Mar 2023
Wow. This is huge. This is the real @LillyPad Eli Lilly cuts insulin price to $35. An issue many of us have been advocating so hard for. #insulin4all nbcnews.com/news/amp/rcna727…

Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions

The move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.

nbcnews.com
2
368
Steve Spellman retweeted
NMDP (@nmdp_org) profile picture
NMDP@nmdp_org23 Feb 2023
🎧 Tune in to the must-hear 100th episode of The @OncoZine Brief with our very own @spellman_s. Find out how mismatched unrelated donors (#MMUD) hold the key to erasing the gap in donor availability for #HCT 👉 ms.spr.ly/60195u00t
Image from NMDP (@nmdp_org)
2
11
976
The @CIBMTR #GVHD Working Committee is conducting critical studies into treatment strategies to prevent and treat GVHD. Let’s work together to improve outcomes post-transplant. Join us! #gvhdday @BeTheMatch @ASTCT
Image from Steve Spellman (@spellman_s)
1
4
35
2,602
Steve Spellman retweeted
Jeff Auletta (@JeffAuletta) profile picture
Jeff Auletta@JeffAuletta19 Jan 2023
Great testament to the efforts of our transplant and cell therapy ecosystem and that of our staff who make the @CIBMTR a great data resource for our community! @BeTheMatch @ASTCT
CIBMTR (@CIBMTR) profile pictureCIBMTR@CIBMTR18 Jan 2023
The 2022 CIBMTR Annual Report is now available to view on our website. Thank you for helping us make 2022 another successful year! cibmtr.org/CIBMTR/About/Admi…
Image from CIBMTR (@CIBMTR)
3
19
2,386
Favorable 3 year outcomes in mismatched unrelated donor HCT using PTCy based GVHD prophy. No difference in outcomes observed between 7/8 and <7/8 matched donors. @cibmtr @nmdp Open access link - authors.elsevier.com/c/1gRmb…
5
18
2,034
#ASH22 LBA personally proud to see @BMTCTN showing superior GRFS with PTCY in RIC #allo. Practice changing. No negative impact on OS, PFS, relapse. When surviving important to service without #gvhd @OncLive @sghmd @GvHD_Meade – at New Orleans, LA
Image from Mehdi Hamadani, MD (@MediHumdani)
Image from Mehdi Hamadani, MD (@MediHumdani)
Image from Mehdi Hamadani, MD (@MediHumdani)
Image from Mehdi Hamadani, MD (@MediHumdani)
1
19
2
52
Load more